MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanders-Bush, E.
Right arrow Articles by Hazelwood, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanders-Bush, E.
Right arrow Articles by Hazelwood, L.
Molecular Interventions 3:319-330 (2003)
© 2003 American Society of Pharmacology and Experimental Therapeutics


Review

Serotonin 5-HT2 Receptors: Molecular and Genomic Diversity

Elaine Sanders-Bush, Hugh Fentress and Lisa Hazelwood

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232


Genetic and molecular events regulate the creation of variants of 5-HT2A and 5-HT2C receptors whose diversity has important functional significance. Overall sequence identity between the 5-HT2A and 5-HT2C receptors is quite high and it is not surprising that the mechanisms of regulation for these two receptors are similar. There is, however, one striking difference: RNA editing, a mechanism for generating molecular diversity by altering the genetic code at the level of RNA. The 5-HT2C receptor is the only G protein–coupled receptor known to be edited. We examine the process of editing, as well as more common genetic modifications, at the cellular level and in human disease.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. F. Lopez-Gimenez, M. T. Vilaro, and G. Milligan
Morphine Desensitization, Internalization, and Down-Regulation of the {micro} Opioid Receptor Is Facilitated by Serotonin 5-Hydroxytryptamine2A Receptor Coactivation
Mol. Pharmacol., November 1, 2008; 74(5): 1278 - 1291.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Dai, N. L. Dudek, T. B. Patel, and N. A. Muma
Transglutaminase-Catalyzed Transamidation: A Novel Mechanism for Rac1 Activation by 5-Hydroxytryptamine2A Receptor Stimulation
J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 153 - 162.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.